Medical Crossfire®: Clinical Decision Making Under New Paradigms for HR+/HER2-Breast Cancer

December 6, 2022 @ 6:30 pm 9:00 pm CST

Supported By: educational grants from Gilead, Menarini-Stemline, Sanofi Genzyme, and Veru, Inc.

Program Description

This Medical Crossfire® program will be presented at the 2022 San Antonio Breast Cancer Symposium, to be held in San Antonio, Texas, and will provide a forum for expert breast oncologists to discuss state-of-the-art care for HR+/HER2- breast cancers. The case-based, interactive agenda will allow the faculty to highlight how new and established clinical trial data can be integrated into real-world patient scenarios. Discussion topics will include individualized treatment planning that incorporates the latest evidence and treatment options in the context of our evolving understanding of the disease’s biology. Additionally, faculty will discuss how emerging agents may impact treatment paradigms in the near future.


Joyce O’Shaughnessy, MD
Baylor University Medical Center
Celebrating Woman Chair in Breast Cancer Research
Dallas, TX

The US Oncology Network
Chair, Breast Cancer Research Program
Dallas, TX